ATG5 and cancer: Similarly, the glycolysis inhibitors 3-BrPA, 2-DG, lonidamine and DCA demonstrate greater cytotoxicity in ATG7 [126,129,130] or ATG5 [111] knockdown cancer cell lines than in the corresponding wild-type cell lines, as was evidenced by decreased viability and proliferation and increased cell death.